Tedco awards $600K to tech firms - Puget Sound Business Journal (Seattle):

lyubomiradete.blogspot.com
The money was granted in collaboration withthe U.S. Army Medical Research and Materiel Command and the throughthe Ft. Detricko Technology Transfer Initiative. The purpose of the technology transfe r program is to raise awareness of new and developinbg technologies and funding them to transition as viablde projectsfor follow-on funding in the market Each company that received funding was awarded approximately $50,000 betweenb March 2008 and May 2009, makingt up the initiative’s second round of financial awardes since its $750,000 program The funds for the program’s seconx phase were secured by Sen. Barbarw Mikulski, D-Md., and Rep. Roscoe G. Bartlett, “The [Ft.
Detrick Technologgy Transfer Initiative] program is enabling area businessese to harness the technologies beinfg developed at Fort Detrick and apply them to thecommercialp sector,” said Mikulski. “This will lead to new producta that have the power to creater jobs andsave lives.” Mikulski announcedf the first phase of the tech transfetr program in March 2005 when 11 companie s received funding.
in Rockville: The company is developinf a health care technology called miTag which is a scalable wirelessw sensor solution for improving patient in Frederick: The company is developing a technology called the GeNov a Screen to identify, isolate, and produce antibody-like in Rockville: The company is developingb an on-demand biotech products including a combination vaccinr against plague and anthrax. BioAssay Works LLC in The company is developinga lateral-flo visual diagnostic test to detect and differentiate singlee sample multiple pathogenic poxviruses, including vaccinia, and monkeypox.
in Catonsville: The compan y is safety-testing a medical producy called ClotFoam, which is a non-compressible, intracavitarg hemostatic agent. CynerGene IDMP in Frederick: The companyg is developing, validating and implementing a supplemental diagnosisof Malaria, HIV, and Dengue usinh its Infectious Disease Multiplex Panelp approach, which could allow for creatioh of biosensors. LLC in Baltimore: The compangy is developing required components and system frameworik to enable conversational interfaces fortelemedicines tools. Such tools would allow professional medicx touse voice, and other human-- computeer interactions to access and document information in electronic medical records.
in The company is developing technology to preserve mammalian cellse in dried format that can easilyube re-hydrated for a variety of uses. LLC in The company is evaluating the effect of Imagilinm patented probiotics as a food supplemen to enhance the immune responsiveness of guinea pigs upon immunization or challengre withvirulent pathogens. The evaluatio n will suggest the ability of Imagilin patented probioticds to enhance the immunization of a in Baltimore: The companty is developing micropatterned substrates for viral infectivityy assays. Juxtopia in Baltimore: The company is customizing its Wearable Assistance and SituationaloAwareness (WASA) goggles and service to allow U.S.
Army combaft medics to access and document informatiomn to electrical medical recordsvia hands-freee voice-requests and voice-responses. in Baltimore: The company is developingv cell therapies to treat brain and spina lcord injuries.